Literature DB >> 15282348

Treating hepatitis C in "difficult-to-treat" patients.

Jean-Michel Pawlotsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15282348     DOI： 10.1056/NEJMp048068

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Therapeutic implications of hepatitis C virus resistance to antiviral drugs.

Authors:  Jean-Michel Pawlotsky
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Emerging therapies for chronic hepatitis C virus.

Authors:  Paul J Pockros
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

Review 3.  Hepatitis C virus: virology, diagnosis and management of antiviral therapy.

Authors:  Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

4.  Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Sanjay Basu; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

5.  Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006.

Authors:  Francois Roman; Karin Hawotte; Daniel Struck; Anne-Marie Ternes; Jean-Yves Servais; Vic Arendt; Patrick Hoffman; Robert Hemmer; Therese Staub; Carole Seguin-Devaux; Jean-Claude Schmit
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance.

Authors:  Megan H Powdrill; Egor P Tchesnokov; Robert A Kozak; Rodney S Russell; Ross Martin; Evguenia S Svarovskaia; Hongmei Mo; Roger D Kouyos; Matthias Götte
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-01       Impact factor: 11.205

7.  Hepatitis C variability, patterns of resistance, and impact on therapy.

Authors:  Cristina Simona Strahotin; Michael Babich
Journal:  Adv Virol       Date:  2012-07-19

8.  Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease.

Authors:  Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.